Stock Taper 
SOLEUS CAPITAL MANAGEMENT, L.P.
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Xenon Pharmaceuticals Inc. | XENE | 267K | $16.12M |
 LivaNova PLC | LIVN | 254.96K | $20.97M |
 Immunovant, Inc. | IMVT | 252K | $9.71M |
 Kiniksa Pharmaceuticals International, plc | KNSA | 246.35K | $15.75M |
 United Therapeutics Corporation | UTHR | 225.59K | $122.23M |
 Praxis Precision Medicines, Inc. | PRAX | 177.52K | $59.43M |
 Enliven Therapeutics, Inc. | ELVN | 165.68K | $8.41M |
 Solid Biosciences Inc. | SLDB | 150K | $1.5M |
 Spyre Therapeutics, Inc. | SYRE | 147K | $13.05M |
 Nektar Therapeutics | NKTR | 128.36K | $8.96M |
 Twist Bioscience Corporation | TWST | 104.63K | $10.76M |
 Tectonic Therapeutic, Inc. | TECX | 101.68K | $3.5M |
 Insmed Incorporated | INSM | 90.25K | $9.62M |
 UnitedHealth Group Incorporated | UNH | 80K | $33.25M |
 Mirum Pharmaceuticals, Inc. | MIRM | 75K | $8.78M |
 AxoGen, Inc. | AXGN | 57.04K | $2.63M |
 Merck & Co., Inc. | MRK | 50K | $6.42M |
 ArriVent BioPharma, Inc. | AVBP | 50K | $1.74M |
 Cullinan Therapeutics, Inc. | CGEM | 50K | $910.5K |
 Alnylam Pharmaceuticals, Inc. | ALNY | 33.05K | $9.95M |